FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.
... More
